NC Biomatrix: Regenerative Biomaterials for European Strategic Autonomy
NC Biomatrix B.V. is a Dutch deep-tech venture pioneering regenerative biomaterials to combat chronic back pain. Based in Eindhoven and spun out of research at TU Eindhoven in 2019, the company has developed an injectable gel that can restore degenerated spinal discs and alleviate pain[1]. This proprietary biomatrix, derived from biological matrix proteins, offers a non-surgical alternative to spinal fusion or artificial disc implants. Led by an international team of biomedical innovators, NC Biomatrix is translating cutting-edge lab discoveries into a tangible therapy for millions suffering from degenerative disc disease. The company’s early successes – including major European innovation grants and industry partnerships – signal its potential to become a strategic asset in Europe’s emerging biotech and medical technology landscape. By advancing a novel treatment entirely developed and manufactured in Europe, NC Biomatrix exemplifies how home-grown innovation can strengthen European autonomy in critical health technologies while reinforcing resilience across both civilian healthcare and military readiness.